Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17593022 | 1.00 | HTR7 (1.00) | HTR7 | |
| SCHEMBL21628274 | 1.00 | HTR7 (1.00) | HTR7 | |
| SCHEMBL16150983 | 0.94 | HTR7 (1.00) | HTR7 | |
| Hydrochloric Acid SCHEMBL16151313 | 0.93 | HTR7 (0.98) | HTR7 | |
| SCHEMBL17592732 | 0.84 | HTR7 (1.00) | HTR7 | |
| SCHEMBL18227893 | 0.81 | HTR7 (0.77) | HTR7 | |
| SCHEMBL18236185 | 0.80 | HTR7 (0.76) | HTR7 | |
| SCHEMBL18227892 | 0.79 | HTR7 (0.74) | HTR7 | |
| SCHEMBL21628271 | 0.79 | HTR7 (1.00) | HTR7 | |
| SCHEMBL21628291 | 0.79 | HTR7 (1.00) | HTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11192871-B2 | 5-hydroxytryptamine receptor 7 activity modulators and their method of use | TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2021-12-07 | — | — | US | claimed |
| US-20200223810-A1 | NOVEL 5-HYDROXYTRYPTAMINE RECEPTOR 7 ACTIVITY MODULATORS AND THEIR METHOD OF USE | TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2020-07-16 | — | — | US | claimed |
| US-10544117-B2 | 5-hydroxytryptamine receptor 7 activity modulators and their method of use | Temple University—Of the Commonwealth System of Higher Education (US) | 2020-01-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11192871-B2 | 5-hydroxytryptamine receptor 7 activity modulators and their method of use | HTR7, HTR5A, HTR6 | HTR7 1/4885 |
| US-20200223810-A1 | NOVEL 5-HYDROXYTRYPTAMINE RECEPTOR 7 ACTIVITY MODULATORS AND THEIR METHOD OF USE | HTR7, HTR6, HTR5A | HTR7 1/4885 |
| US-10544117-B2 | 5-hydroxytryptamine receptor 7 activity modulators and their method of use | HTR7, HTR5A, HTR6 | HTR7 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.